Vertex Pharmaceuticals Inc
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3028% above fair value
$530.76−22.39 (-4.05%)
Close on Nov 3, 2026Market cap $134.53BP/E 30.9Yield –
Vertex Pharmaceuticals PP&E gross by Year
PP&E gross — Laboratory equipment, other equipment and furniture ($M) ($M)
Vertex Pharmaceuticals PP&E gross: $788M in FY2025, up 15.1% from a year earlier.
Latest, FY2025
788
Period ended Dec 31, 2025
Change on a year earlier
+15.1%
685 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Property and Equipment).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PP&E gross — Laboratory equipment, other equipment and furniture ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 788 | +15.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 685 | +18.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 579 | +21.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 477 | +17.0% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 407 | – | Form 10-K (filed 2023-02-10) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals PP&E gross ($M), annual FY2021–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/ppe-gross-lab
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?